Whitehawk Therapeutics (WHWK) Enterprise Value: 2018-2025
Historic Enterprise Value for Whitehawk Therapeutics (WHWK) over the last 8 years, with Sep 2025 value amounting to -$197.7 million.
- Whitehawk Therapeutics' Enterprise Value fell 1559.79% to -$197.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$685.5 million, marking a year-over-year decrease of 138.35%. This contributed to the annual value of $30.5 million for FY2024, which is 151.47% up from last year.
- Whitehawk Therapeutics' Enterprise Value amounted to -$197.7 million in Q3 2025, which was down 62.91% from -$121.4 million recorded in Q2 2025.
- Over the past 5 years, Whitehawk Therapeutics' Enterprise Value peaked at $355.6 million during Q4 2021, and registered a low of -$197.7 million during Q3 2025.
- Over the past 3 years, Whitehawk Therapeutics' median Enterprise Value value was -$30.8 million (recorded in 2024), while the average stood at -$47.6 million.
- Per our database at Business Quant, Whitehawk Therapeutics' Enterprise Value surged by 923.03% in 2022 and then crashed by 1,707.99% in 2024.
- Over the past 5 years, Whitehawk Therapeutics' Enterprise Value (Quarterly) stood at $355.6 million in 2021, then crashed by 60.51% to $140.4 million in 2022, then slumped by 142.23% to -$59.3 million in 2023, then soared by 151.47% to $30.5 million in 2024, then slumped by 1,559.79% to -$197.7 million in 2025.
- Its Enterprise Value stands at -$197.7 million for Q3 2025, versus -$121.4 million for Q2 2025 and -$147.8 million for Q1 2025.